Mar Drugs, 2026, 24(4):134

Human and Marine Host Defense Peptides for Healthy Skin

The skin serves as the first line barrier of innate immunity, protecting the body from external influences and maintaining its homeostasis. Exogenous and endogenous stress factors alter the structure and functional properties of the skin. The search for compounds capable of counteracting these processes has allowed the identification of peptides as promising ingredients of products for medicinal and cosmetic applications. This review comprehensively examines the mechanisms of action and dermatological applications of two distinct classes of natural products-endogenous human peptides and those derived from marine organisms. Human peptides exhibit numerous biological functions, including antimicrobial and immunomodulatory ones, as well as promoting antioxidant protection and wound healing. Microbiome-associated peptides are an underestimated but powerful regulator of skin aging through immunomodulation, inflammation control, barrier function maintenance, and selection of the proper microbial community. Peptides from marine organisms exhibit significant structural diversity and a broad spectrum of biological activity, including regenerative effects and effects on antibiotic-resistant microorganisms. This review summarizes current data obtained from in vitro, ex vivo, and clinical studies demonstrating a broad potential of peptides for maintaining skin health. Both peptide classes represent powerful, targeted strategies for innovative dermatological interventions aimed at promoting skin rejuvenation, protection, and overall homeostasis.

IBCH: 12590
Ссылка на статью в журнале: https://doi.org/10.3390/md24040134
Нет данных о цитировании
Данные статьи проверены модераторами 2026-09-27

Список научных проектов, где отмечена публикация

  1. Комплексный подход к анализу природных библиотек защитных пептидов: от фундаментальных исследований механизмов антимикробного действия до разработки прототипов новых лекарственных средств для борьбы с антибиотикорезистентными инфекциями (6 Января 2022 года — 31 Декабря 2024 года). Овчинникова Т.В.. Грант, РНФ.